academic article

• Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors. 2016
• Bone marrow-derived CD13(+) cells sustain tumor progression: A potential non-malignant target for anticancer therapy..  Oncoimmunology.  3:-. 2014
• CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis. 2013
• Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings..  Journal of controlled release : official journal of the Controlled Release Society.  170:233-241. 2013